{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:40:54Z","timestamp":1787982054229,"version":"build-2784847793"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.idnow.2021.07.006","type":"journal-article","created":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T11:38:46Z","timestamp":1627731526000},"page":"661-666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Adults at risk of pneumococcal disease in France"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9779-9044","authenticated-orcid":false,"given":"B.","family":"Wyplosz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9306-2571","authenticated-orcid":false,"given":"J.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2699-048X","authenticated-orcid":false,"given":"G.","family":"Goussiaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mo\u00efsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8816-7475","authenticated-orcid":false,"given":"J.","family":"Lortet-Tieulent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Vainchtock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Leboucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7611-371X","authenticated-orcid":false,"given":"F.","family":"Raguideau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idnow.2021.07.006_bib0105","series-title":"Infections \u00e0 pneumocoque","author":"Sant\u00e9 Publique France","year":"2020"},{"key":"10.1016\/j.idnow.2021.07.006_bib0110","series-title":"Who should have the pneumococcal vaccine?","author":"NHS","year":"2019"},{"key":"10.1016\/j.idnow.2021.07.006_bib0115","series-title":"Pneumococcal vaccination summary. Who and when to vaccinate. For providers","author":"Centers for Disease Control and Prevention","year":"2020"},{"key":"10.1016\/j.idnow.2021.07.006_bib0120","doi-asserted-by":"crossref","first-page":"e018553","DOI":"10.1136\/bmjopen-2017-018553","article-title":"Risk of pneumococcal diseases in adults with underlying medical conditions: a retrospective, cohort study using two Japanese healthcare databases","volume":"8","author":"Imai","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.idnow.2021.07.006_bib0125","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1186\/s12879-016-1820-8","article-title":"Influenza and pneumococcal vaccination in Australian adults: a systematic review of coverage and factors associated with uptake","volume":"16","author":"Dyda","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.idnow.2021.07.006_bib0130","series-title":"Avis relatif aux recommandations de la vaccination pour les adultes et les enfants \u00e2g\u00e9s de plus de 2\u00a0ans \u00e0 risque d\u2019infection invasive \u00e0 pneumocoque","author":"Haut Conseil de la Sant\u00e9 Publique","year":"2013"},{"key":"10.1016\/j.idnow.2021.07.006_bib0135","series-title":"Avis relatif aux recommandations vaccinales contre les infections \u00e0 pneumocoque pour les adultes","author":"Haut Conseil de la Sant\u00e9 Publique","year":"2017"},{"key":"10.1016\/j.idnow.2021.07.006_bib0140","series-title":"Donn\u00e9es de couverture vaccinale grippe par groupe d\u2019\u00e2ge","author":"Sant\u00e9 Publique France","year":"2020"},{"issue":"Suppl. 4","key":"10.1016\/j.idnow.2021.07.006_bib0145","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.respe.2017.05.004","article-title":"Value of a national administrative database to guide public decisions: from the syst\u00e8me national d\u2019information interr\u00e9gimes de l\u2019Assurance Maladie (SNIIRAM) to the syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) in France","volume":"65","author":"Tuppin","year":"2017","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.idnow.2021.07.006_bib0150","series-title":"R\u00e9pertoire national interr\u00e9gimes des b\u00e9n\u00e9ficiaires de l\u2019assurance maladie","author":"RNIAM","year":"2018"},{"key":"10.1016\/j.idnow.2021.07.006_bib0155","doi-asserted-by":"crossref","DOI":"10.1093\/eurpub\/ckz185.108","article-title":"The \u201ccartographie\u201d tool (CNAM, France)","volume":"29","author":"Gastaldi-M\u00e9nager","year":"2019","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.idnow.2021.07.006_bib0160","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1016\/j.respe.2018.04.034","article-title":"Identification et estimation de la pr\u00e9valence de l\u2019asthme s\u00e9v\u00e8re en France via l\u2019\u00e9chantillon g\u00e9n\u00e9raliste de b\u00e9n\u00e9ficiaires","volume":"66","author":"Bou\u00e9e","year":"2018","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.idnow.2021.07.006_bib0165","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.diabet.2019.12.006","article-title":"Is the type 2 diabetes epidemic plateauing in France? A nationwide population-based study","volume":"46","author":"Fuentes","year":"2020","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.idnow.2021.07.006_bib0170","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nephro.2016.07.446","article-title":"[Management of patients with end-stage renal disease prior to initiation of renal replacement therapy in 2013 in France]","volume":"13","author":"Tuppin","year":"2017","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.idnow.2021.07.006_bib0175","series-title":"Cartographie des pathologies et des d\u00e9penses 2017","author":"Assurance Maladie","year":"2019"},{"key":"10.1016\/j.idnow.2021.07.006_bib0180","series-title":"L\u2019\u00e9tat de sant\u00e9 de la population en France. Rapport 2017","author":"Sant\u00e9 Publique France","year":"2017"},{"key":"10.1016\/j.idnow.2021.07.006_bib0185","series-title":"Le rapport m\u00e9dical et scientifique du pr\u00e9l\u00e8vement et de la greffe en France","author":"Agence de la biom\u00e9decine","year":"2018"},{"key":"10.1016\/j.idnow.2021.07.006_bib0190","series-title":"Sida et VIH","author":"INSERM","year":"2018"},{"key":"10.1016\/j.idnow.2021.07.006_bib0195","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1186\/s12879-015-1162-y","article-title":"Rates of pneumonia among children and adults with chronic medical conditions in Germany","volume":"15","author":"Pelton","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.idnow.2021.07.006_bib0200","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12913-016-1432-4","article-title":"Rates and costs of invasive pneumococcal disease and pneumonia in persons with underlying medical conditions","volume":"16","author":"Weycker","year":"2016","journal-title":"BMC Health Serv Res"}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266699192100470X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266699192100470X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:31:15Z","timestamp":1763019075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266699192100470X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S266699192100470X"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2021.07.006","relation":{},"ISSN":["2666-9919"],"issn-type":[{"value":"2666-9919","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adults at risk of pneumococcal disease in France","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2021.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}